When intended parents begin researching IVF clinics, success rate figures are usually the first thing they encounter. A headline number — "65% success rate" or "top-ranked clinic" — can feel reassuring, but without understanding what that figure actually measures, it may tell you very little about the likelihood of a positive outcome in your specific situation. This guide explains how to interpret these statistics critically, so that you can make comparisons that are genuinely useful.
No single definition of "success" is universally applied across clinics or countries. The figure quoted might refer to any of the following, and the distinctions matter enormously.
A clinic that publishes a positive pregnancy test rate of 70% may have a live birth rate considerably lower. Always identify which endpoint a published figure represents before drawing any conclusions.
Reproductive outcomes decline significantly with the age of the egg provider. A clinic treating a younger patient population will naturally report higher aggregate success rates than one specialising in complex or older-patient cases, regardless of clinical quality. This effect is substantial enough to make headline comparisons between clinics nearly meaningless unless age stratification is provided.
When reviewing a clinic's published data, look for figures broken down by age bracket — typically under 35, 35–37, 38–39, 40–42, and 43 and above. If a clinic presents only a single aggregate figure, treat it with considerable caution. Regulatory bodies in some countries, such as the Human Fertilisation and Embryology Authority (HFEA) in the United Kingdom, require clinics to report outcomes by age group, which makes their published data more comparable. If you are considering a clinic overseas, check whether equivalent regulatory reporting requirements exist in that jurisdiction.
You can read more about how regulatory environments differ across destinations on our countries overview page.
Another critical distinction is whether a rate is calculated per embryo transfer or per cycle started (also called per egg collection or per retrieval).
A clinic might report a 55% live birth rate per transfer while its rate per cycle started is closer to 35%, simply because a proportion of cycles do not produce transferable embryos. Neither figure is dishonest in isolation, but knowing which is which changes the picture significantly.
Clinics that restrict the cases they accept — declining patients with poor prognosis or complex histories — will report higher success rates without necessarily being more skilled. Equally, a high-volume clinic that accepts difficult cases may show lower published rates despite delivering excellent care to patients who would be turned away elsewhere.
When speaking to a clinic, it is reasonable to ask what proportion of patients they decline or redirect, and whether their published figures include donor egg cycles separately from own-egg cycles. Donor egg cycles typically carry higher success rates because the eggs come from younger donors; pooling them with own-egg cycles in a single headline figure can be misleading.
Armed with the above framework, the following questions will help you extract meaningful information during any clinic consultation.
A clinic that is unwilling or unable to answer these questions clearly warrants further scrutiny. Transparent clinics will generally welcome informed questions and offer documentation rather than deflecting to marketing materials.
Success rates also reflect factors that are difficult to observe from the outside: embryology laboratory conditions, air quality, culture media, freezing protocols, and the experience of the embryology team. Two clinics may use identical stimulation protocols yet achieve different blastocyst development rates because of differences in laboratory practice. When visiting a clinic — in person or virtually — it is worth asking about laboratory accreditation and whether the embryology team is stable or subject to high turnover.
For intended parents using a surrogate, the transfer environment matters as well. You can find an outline of how a typical programme is structured on our how it works page.
In the United Kingdom, the HFEA publishes clinic-by-clinic outcome data that is age-stratified and independently collected. In the United States, the Centers for Disease Control and Prevention (CDC) and the Society for Assisted Reproductive Technology (SART) publish annual reports covering most clinics. Other countries have varying levels of mandatory reporting; some have none at all. Where independent data exists, it should be your primary reference rather than figures drawn from a clinic's own marketing materials.
If you are exploring a programme in a country without robust regulatory reporting, additional due diligence becomes particularly important. Our programmes section provides guidance on how ReproLegal assesses clinic standards in different jurisdictions.
Before placing significant weight on any success rate figure, work through the following checklist.
If you have questions about costs associated with multiple cycles or what a typical programme budget looks like, our costs overview provides a structured breakdown.
Even the most carefully interpreted success rate is a population statistic. It describes what happened across a group of patients and cannot predict what will happen in any individual case. The purpose of understanding these figures is to enable more informed conversations with clinicians and to avoid being misled by numbers designed to attract rather than inform. A clinic with a slightly lower published rate may be a better fit for your circumstances than one with a headline-grabbing figure built on a carefully selected patient population.
Approach these conversations with curiosity rather than anxiety, and do not hesitate to seek a second clinical opinion before committing to a programme.
This article is intended for general informational purposes only and does not constitute medical or legal advice. Regulatory frameworks and clinical standards vary by country and change over time; all figures, legal positions and procedural descriptions should be confirmed with qualified medical professionals and local legal counsel before any decisions are made.